← Leaderboards
Dokyoon Kim
Indiana University Indianapolis
$5,147,076
Attributed
$9,787,337
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,787,337 · 4
By mechanism
R01$9,787,337 · 4
Top collaborators
- Xia Ning5 shared
- Li Shen5 shared
- Sungeun Kim4 shared
- Kwangsik Timothy Nho4 shared
- Marylyn D Ritchie3 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Sara K Quinney$11,876,528
- Paul Richard Territo$22,416,914
- Adrian Lynn Oblak$5,075,046
- Li Shen$13,717,828
- Brian E. Dixon$5,147,904
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMachine LearningGeneticInformaticsPhenotypeCohortComplexPreventionClinical DataMolecularTranslatingMedicineGenesBig DataElectronic Health RecordData IntegrationPublic HealthVariantGenetic VariantRare VariantBioinformaticsAlgorithmsBig Data MethodsNetwork-Based
Grant awards (17)
Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease$769,981
R01 · FY2025 · HL · contact PI
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$714,545
R01 · FY2025 · AG
Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease$771,338
R01 · FY2024 · HL
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$745,370
R01 · FY2024 · AG
Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease$804,781
R01 · FY2023 · HL
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$761,646
R01 · FY2023 · AG
Unravelling genetic basis of comorbidity using EHR-linked biobank data$474,964
R01 · FY2023 · GM · contact PI
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$777,939
R01 · FY2022 · AG
Unravelling genetic basis of comorbidity using EHR-linked biobank data$474,964
R01 · FY2022 · GM · contact PI
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease$809,200
R01 · FY2021 · AG
Unravelling genetic basis of comorbidity using EHR-linked biobank data$479,368
R01 · FY2021 · GM · contact PI
Unravelling genetic basis of comorbidity using EHR-linked biobank data$325,000
R01 · FY2021 · GM · contact PI
Unravelling genetic basis of comorbidity using EHR-linked biobank data$486,125
R01 · FY2020 · GM · contact PI
Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease$341,471
R01 · FY2020 · LM
Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease$341,691
R01 · FY2019 · LM
Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease$341,899
R01 · FY2018 · LM
Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease$367,055
R01 · FY2017 · LM